Baidu
map

世界中联首届非遗高峰论坛举办:向世界讲好中医药非遗故事c

2018-06-21 葛伟韬 中国中医

每年6月的第二个星期六是我国文化和自然遗产日。6月13日,世界中医药学会联合会首届非物质文化遗产高峰论坛在京举办,世界中医药非遗时讯项目同期启动,旨在向世界讲好中医药非遗故事,传播中医药非遗声音。

每年6月的第二个星期六是我国文化和自然遗产日。6月13日,世界中医药学会联合会首届非物质文化遗产高峰论坛在京举办,世界中医药非遗时讯项目同期启动,旨在向世界讲好中医药非遗故事,传播中医药非遗声音。

论坛上,中国人民外交学会名誉会长李肇星表示,自己与中医药有着不解之缘,在成长的过程中因为中医药获得了身体上的健康,受益匪浅。“工作以后还发现,中医药在世界上享有越来越高的声誉,为世界人民谋的福祉也越来越多。”

世界中医药非遗时讯项目将整理、收集中医药非遗项目最新动态,涵盖中国国家级、省级、市级等非遗项目保护及发展情况,境外中医药非遗传承情况等内容,定期向联合国教科文组织及相关部委汇报中医药非遗最新情况,并以《世界中医药非遗时讯》中英双语线上刊物、线下内部刊物、宣传视频等多种形式向世界中联全球30万终端会员发布中医药非遗讯息。

世界中联副主席兼秘书长桑滨生表示,世界中联将更加关注中医药的整体发展,开展中医药非遗保护和研究,努力打造中医药非遗国际传播平台,全力构建中医药非遗的保护、传承、体验、分享体系,让世界更好地认识中医药、感知中医药、了解中医药。

世界中联将于每年6月的文化和自然遗产日举办非物质文化遗产高峰论坛。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1819722, encodeId=f55e1819e2279, content=<a href='/topic/show?id=abf799e1513' target=_blank style='color:#2F92EE;'>#非遗故事#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99715, encryptionId=abf799e1513, topicName=非遗故事)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Wed Nov 07 04:51:00 CST 2018, time=2018-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662933, encodeId=894d1662933a5, content=<a href='/topic/show?id=0f1d102351f0' target=_blank style='color:#2F92EE;'>#高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102351, encryptionId=0f1d102351f0, topicName=高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad825519092, createdName=斯嘉莉, createdTime=Tue Oct 23 19:51:00 CST 2018, time=2018-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819723, encodeId=d7c81819e23a2, content=<a href='/topic/show?id=0a0b99e171f' target=_blank style='color:#2F92EE;'>#非遗高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99717, encryptionId=0a0b99e171f, topicName=非遗高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Sat Dec 15 19:51:00 CST 2018, time=2018-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409583, encodeId=f7ea1409583d6, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Jun 23 09:51:00 CST 2018, time=2018-06-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1819722, encodeId=f55e1819e2279, content=<a href='/topic/show?id=abf799e1513' target=_blank style='color:#2F92EE;'>#非遗故事#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99715, encryptionId=abf799e1513, topicName=非遗故事)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Wed Nov 07 04:51:00 CST 2018, time=2018-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662933, encodeId=894d1662933a5, content=<a href='/topic/show?id=0f1d102351f0' target=_blank style='color:#2F92EE;'>#高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102351, encryptionId=0f1d102351f0, topicName=高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad825519092, createdName=斯嘉莉, createdTime=Tue Oct 23 19:51:00 CST 2018, time=2018-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819723, encodeId=d7c81819e23a2, content=<a href='/topic/show?id=0a0b99e171f' target=_blank style='color:#2F92EE;'>#非遗高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99717, encryptionId=0a0b99e171f, topicName=非遗高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Sat Dec 15 19:51:00 CST 2018, time=2018-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409583, encodeId=f7ea1409583d6, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Jun 23 09:51:00 CST 2018, time=2018-06-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1819722, encodeId=f55e1819e2279, content=<a href='/topic/show?id=abf799e1513' target=_blank style='color:#2F92EE;'>#非遗故事#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99715, encryptionId=abf799e1513, topicName=非遗故事)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Wed Nov 07 04:51:00 CST 2018, time=2018-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662933, encodeId=894d1662933a5, content=<a href='/topic/show?id=0f1d102351f0' target=_blank style='color:#2F92EE;'>#高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102351, encryptionId=0f1d102351f0, topicName=高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad825519092, createdName=斯嘉莉, createdTime=Tue Oct 23 19:51:00 CST 2018, time=2018-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819723, encodeId=d7c81819e23a2, content=<a href='/topic/show?id=0a0b99e171f' target=_blank style='color:#2F92EE;'>#非遗高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99717, encryptionId=0a0b99e171f, topicName=非遗高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Sat Dec 15 19:51:00 CST 2018, time=2018-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409583, encodeId=f7ea1409583d6, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Jun 23 09:51:00 CST 2018, time=2018-06-23, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1819722, encodeId=f55e1819e2279, content=<a href='/topic/show?id=abf799e1513' target=_blank style='color:#2F92EE;'>#非遗故事#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99715, encryptionId=abf799e1513, topicName=非遗故事)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6976269, createdName=zhangph, createdTime=Wed Nov 07 04:51:00 CST 2018, time=2018-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1662933, encodeId=894d1662933a5, content=<a href='/topic/show?id=0f1d102351f0' target=_blank style='color:#2F92EE;'>#高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102351, encryptionId=0f1d102351f0, topicName=高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bad825519092, createdName=斯嘉莉, createdTime=Tue Oct 23 19:51:00 CST 2018, time=2018-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819723, encodeId=d7c81819e23a2, content=<a href='/topic/show?id=0a0b99e171f' target=_blank style='color:#2F92EE;'>#非遗高峰论坛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99717, encryptionId=0a0b99e171f, topicName=非遗高峰论坛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Sat Dec 15 19:51:00 CST 2018, time=2018-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409583, encodeId=f7ea1409583d6, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sat Jun 23 09:51:00 CST 2018, time=2018-06-23, status=1, ipAttribution=)]
    2018-06-23 cathymary

相关资讯

世界中联国际中医药专病指南发布

中国中医科学院首席研究员仝小林及其团队11月14日在广东省深圳市发布其主持编制的《国际中医药糖尿病诊疗指南》。这是世界中医药学会联合会的首部国际中医药专病诊疗指南。

世界中联:努力开创新时代中医药国际发展新局面

1月27日,世界中医药学会联合会2018年分支机构会长级会议在京召开。会议要求努力开创新时代中医药国际发展新局面。

Baidu
map
Baidu
map
Baidu
map